Free Newsletter
Another company recalls fentaynl patch
Different manufacturer, same problem. Another company is recalling painkiller patches because of a flaw that could cause patients or caregivers to overdose on the fentanyl drug inside.
The new recall covers 14 lots of patches sold by Actavis; they have that company's name and its former name, Abrika Pharmaceuticals, on their packaging. Actavis said its patches have a "foldover defect" that might cause leaks. Last week, PriCara, a division of Johnson & Johnson withdrew batches of its Duragesic fentanyl patches. In the latter case, some of the patches had slits in the drug reservoir, leaking fentanyl into the packaging.
Quite a coincidence. Or did the news of J&J's recall alert Actavis to the possibility of a design flaw in its own product?
- see Actavis' release
- see the news in the Washington Post
Related Article:
Millions of fentanyl patches recalled. Report
Comments
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession






SHARE
WITH: